Report Scope & Overview:
The Cardiology Information System (CIS) Market Size was valued at USD 1051.77 million in 2022, and is expected to reach USD 2158.03 million by 2030, and grow at a CAGR of 9.4% over the forecast period 2023-2030.
A system that makes it simple to gather clinical data and research materials from all cardiac departments is referred to as a cardiology information system. The integration, management, and streamlining of the cardiac information flow via the cardiology information system allows for faster data supply, distribution, and analysis. The programme streamlines operations while providing clinicians with access to ECG data for patients. It consists of a variety of elements, including software, hardware, and services. CVIS facilitates information sharing, decision assistance, and scientific growth in the field of cardiovascular research, resulting in improved performance.
To get more information on Cardiology Information System Market - Request Sample Report
Cardiovascular Information Systems (CIS) and Cardiology Picture Archiving and Communication Systems (CPACS) are two important frameworks that are incorporated into the Cardiovascular information system (CVIS). While CVIS is more data-driven and relevant to patient informatics from integrated hemodynamics framework, reverberation machines, and Electrocardiogram (ECG) trucks, CPACS focuses primarily on capacity and recovery of cardiology-driven images. Such an Electronic Health Records System was introduced to clinics and providers of medical services by National Health Portal (NHP), an administration association in India. An EHR framework, for instance, was given by medical service providers and urgent care facilities under the auspices of the public authority association National Health Portal (NHP) India.
MARKET DYNAMICS
DRIVERS
Global Cardiac Disease Prevalence is Growing, and Stroke-Related Deaths Are Rising
Increasing Research and Development to Create New Technologies for Cardiac Stroke Management
RESTRAINTS
Systems are expensive, and regulations are strict.
As there is no established protocol, healthcare providers are reluctant to implement CIS.
OPPORTUNITIES
Application of Cloud-Based Solutions
CHALLENGES
Combining interoperability with integration
IMPACT OF COVID-19
The market for cardiology information systems (CIS) is anticipated to benefit from COVID-19. Medical supplies like masks, gloves, and protective eyewear saw a large rise in demand as a result of COVID-19. The need for medical supplies from both healthcare providers and the general people to take prophylactic measures is growing as the number of COVID-19 cases rises globally. By maintaining a consistent supply of personal protective equipment in the cardiac information system (CIS) industry, the producers of these goods have the chance to benefit from the expanding demand for medical products.
By Mode of Operation
Web-based, onsite, and on-premises solutions make up the three market segments. The market segment that uses cloud technology is expanding at the most notable rate. It is necessary for the web-based segment to account for the largest share of the market. Better interoperability, remote access to images and information, and reduced IT issue in medical clinics via internet are some of the factors that are propelling market growth in this mode of operation sector.
By Component Type
Hardware, software, and services make up the market segments. The market share that belonged to the software sector was greatest. The significant market share in this area can be ascribed to the expanding need for CVIS integration with C-PACS, EMRs, and other cardiac modules.
By End User
Clinics, hospitals, outpatient surgery centres, and other businesses make up the market segments. The segment for medical clinics must account for the largest share of the market. Due to the significant purchasing power of large clinics, the market development in this end-client segment is being driven by the high selection rate of CVIS arrangements.
KEY MARKET SEGMENTS:
By Mode of Operation
Web-Based
Onsite
By Component Type
Software
Services
Hardware
By End User
Hospital
Clinics
Ambulatory Surgical Centers
Need any customization research on Cardiology Information System Market - Enquiry Now
REGIONAL ANALYSIS
The North American, Asia Pacific, and Rest of the World regions make up the global market for cardiology information systems. Geographically, North America, followed by Europe, dominates the market for cardiology information systems. Strict privacy and security laws, as well as the rising prevalence of cardiovascular disorders, are the main drivers of growth in the North American market.
REGIONAL COVERAGE:
North America
USA
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Rest of Europe
Asia-Pacific
Japan
south Korea
China
India
Australia
Rest of Asia-Pacific
The Middle East & Africa
Israel
UAE
South Africa
Rest of Middle East & Africa
Latin America
Brazil
Argentina
Rest of Latin America
KEY PLAYERS:
Some of the major key players are as follows: GE Healthcare, CREALIFE Medical Technology, Lumedx, Esasote, Cerner Corporation, Fujifilm Medical Systems, McKesson Corporation, Simens Healthineers AG, Merge Healthcare Inc, Philips Healthcare, Cerner Corporation and Other Players
Report Attributes | Details |
---|---|
Market Size in 2022 | US$ 1051.77 Million |
Market Size by 2030 | US$ 2158.031Million |
CAGR | CAGR of 9.4% From 2023 to 2030 |
Base Year | 2022 |
Forecast Period | 2023-2030 |
Historical Data | 2020-2021 |
Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
Key Segments | • By Mode of Operation (Web-Based, On-Premises, Onsite) • By Component Type (Software, Services, Hardware) • By End User (Hospital, Clinics, Ambulatory Surgical Centers) |
Regional Analysis/Coverage | North America (USA, Canada, Mexico), Europe (Germany, UK, France, Italy, Spain, Netherlands, Rest of Europe), Asia-Pacific (Japan, South Korea, China, India, Australia, Rest of Asia-Pacific), The Middle East & Africa (Israel, UAE, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) |
Company Profiles | GE Healthcare, CREALIFE Medical Technology, Lumedx, Esasote, Cerner Corporation, Fujifilm Medical Systems, McKesson Corporation, Simens Healthineers AG, Merge Healthcare Inc, Philips Healthcare, Cerner Corporation. |
DRIVERS | • Global Cardiac Disease Prevalence is Growing, and Stroke-Related Deaths Are Rising • Increasing Research and Development to Create New Technologies for Cardiac Stroke Management |
RESTRAINTS | • Systems are expensive, and regulations are strict. • As there is no established protocol, healthcare providers are reluctant to implement CIS.es |
Ans: The Cardiology Information System (CIS) Market is to Grow is at a CAGR of 9.4% over the forecast period 2023-2030.
Ans: The Cardiology Information System (CIS) Market size was valued at US$ 1051.77 million in 2022.
Cardiology Information System (CIS)Market is divided into three segments is By Mode of Operation, By Component Type, and By End User
North America, followed by Europe, dominates the market for cardiology information systems.
The market share that belonged to the software sector was the greatest.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 COVID 19 Impact Analysis
4.2 Impact of Ukraine ware
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Cardiology Information System (CIS) Market Segmentation, By Mode of Operation
8.1 Web-Based
8.2 On-Premises
8.3 Onsite
9. Cardiology Information System (CIS) Market Segmentation, By Component Type
9.1 Software
9.2 Services
9.3 Hardware
10. Cardiology Information System (CIS) Market Segmentation, By End User
10.1 Hospital
10.2 Clinics
10.3 Ambulatory Surgical Centers
11. Regional Analysis
11.1 Introduction
11.2 North America
11.2.1 USA
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 France
11.3.4 Italy
11.3.5 Spain
11.3.6 The Netherlands
11.3.7 Rest of Europe
11.4 Asia-Pacific
11.4.1 Japan
11.4.2 South Korea
11.4.3 China
11.4.4 India
11.4.5 Australia
11.4.6 Rest of Asia-Pacific
11.5 The Middle East & Africa
11.5.1 Israel
11.5.2 UAE
11.5.3 South Africa
11.5.4 Rest
11.6 Latin America
11.6.1 Brazil
11.6.2 Argentina
11.6.3 Rest of Latin America
12.Company Profiles
12.1 GE Healthcare
12.1.1 Financial
12.1.2 Products/ Services Offered
12.1.3 SWOT Analysis
12.1.4 The SNS view
12.2 CREALIFE Medical Technology
12.3 Lumedx
12.4 Esasote
12.5 Cerner Corporation
12.6 Fujifilm Medical Systems
12.7 McKesson Corporation
12.8 Simens Healthineers AG
12.9 Merge Healthcare Inc
12.10 Philips Healthcare
13.Competitive Landscape
13.1 Competitive Benchmark
13.2 Market Share Analysis
13.3 Recent Developments
14.Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Ureteroscope Market size was USD 832.74 Million in 2022 and is expected to Reach USD 1297.50 Million by 2030 and grow at a CAGR of 5.7% over the forecast period of 2023-2030.
The size was valued at USD 448.25 Million in 2022 and is expected to reach USD 618.20 Million By 2030 and grow at a CAGR of 4.1% over the forecast period of 2023-2030.
The Intraoral Cameras Market size was estimated USD 1.8 billion in 2022 and is expected to reach USD 3.7 billion by 2030 at a CAGR of 9.6% during the forecast period of 2023-2030.
In 2022, The Neonatal Respiratory Care Devices Market size amounted to USD 1715.45 Million & is estimated to reach USD 2734.16 Million by 2030 and increase at a compound annual growth rate of 6% between 2023 and 2030.
The Nanomedicine Market Size was valued at USD 170.47 billion in 2022, and is expected to reach USD 431.21 billion by 2030 and grow at a CAGR of 12.3% over the forecast period 2023-2030.
The Contrast Media/Contrast Agent Market Size was valued at USD 4.35 billion in 2022 and is expected to reach USD 5.87 billion by 2030 and grow at a CAGR of 3.8% over the forecast period 2023-2030.
Hi! Click one of our member below to chat on Phone